I 123 ‐FP‐CIT ( DaTSCAN ) SPECT beyond the Most Common Causes of Parkinsonism: A Systematic Review
- 1 May 2024
- journal article
- review article
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 11 (6) , 613-625
Abstract
Background: As the diagnosis of Parkinson's disease (PD) is fundamentally clinical, the usefulness of ioflupane ( 123 I) single‐photon emission computed tomography (SPECT) or DaTSCAN as a diagnostic tool has been a matter of debate for years. The performance of DaTSCAN is generally recommended in the follow‐up of patients with a clinically uncertain diagnosis, especially in those with a suspected essential tremor, drug‐induced parkinsonism, or vascular parkinsonism. However, there is a dearth of DaTSCAN findings regarding neurodegenerative parkinsonisms besides PD and atypical parkinsonisms. To date, a specific nigrostriatal dopamine uptake pattern that would help differentiate PD from the most frequent atypical parkinsonisms is yet to be described. This fact is further complicated by the possible visualization of abnormalities in the uptake pattern in patients with rarer neurodegenerative parkinsonisms. Objectives: We aimed to summarize the current literature regarding DaTSCAN findings in patients with rare neurodegenerative parkinsonisms. Methods: The PubMed database was systematically screened for studies in English or Spanish up to October 15, 2023, using search terms “DaTSCAN”, “ioflupane”, “DaT‐SPECT”, “123I‐FP‐CIT SPECT”, “dopamine transporter imaging”, and “[123I] FP‐CIT SPECT”. Duplicated publications and studies regarding PD, atypical parkinsonisms, dystonia‐parkinsonism, essential tremor, and parkinsonism due to non‐degenerative causes were excluded. Results: The obtained results were reviewed and summarized, including DaTSCAN findings in fragile X‐associated tremor/ataxia syndrome, prion diseases, Huntington's disease, spinocerebellar ataxia, hereditary spastic paraparesis, metabolic disorders, and other diseases (anti‐IgLON5 disease, ring chromosome 20 syndrome, chorea‐acanthocytosis, and neuronal ceroid lipofuscinosis). Conclusions: This review highlights the need to determine in the future the utility and cost‐effectiveness of DaTSCAN, both as a diagnostic and a prognostic tool, in patients with parkinsonian symptoms in rare neurodegenerative diseases.Keywords
This publication has 68 references indexed in Scilit:
- Atypical Parkinsonism with Pathological Dopamine Transporter Imaging in Neuronal Ceroid Lipofuscinosis Type 5Movement Disorders Clinical Practice, 2022
- Abnormal DaTscan in GM1‐Gangliosidosis Type III Manifesting with Dystonia‐ParkinsonismMovement Disorders Clinical Practice, 2022
- Single Photon Emission Computed Tomography/Positron Emission Tomography Molecular Imaging for Parkinsonism: A Fast‐Developing FieldAnnals of Neurology, 2021
- Corticobasal Syndrome in a Patient with Anti‐IgLON5 AntibodiesMovement Disorders Clinical Practice, 2020
- Abnormal DaTSCAN and Atypical Parkinsonism in SCA12Movement Disorders Clinical Practice, 2019
- SPG7: The Great Imitator of MSA‐C Within the ILOCAsMovement Disorders Clinical Practice, 2018
- Gaze Palsy, Sleep and Gait Disorder, as Well as Tako‐Tsubo Syndrome in a Patient with IgLON5 AntibodiesMovement Disorders Clinical Practice, 2016
- MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 2015
- Evidence for pre and postsynaptic nigrostriatal dysfunction in the fragile X tremor–Ataxia syndromeMovement Disorders, 2009
- Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3‐year European multicenter study with repeat [123I]FP‐CIT SPECTMovement Disorders, 2009